During the serious recession of 2008 and 2009, the healthcare industry was one of the few actual growth areas, just as the USA was in the news due to the president’s intended healthcare reform and the consequent, lengthy delays in Congress. Indeed, the healthcare business was a pivotal part of Obama’s campaign and he wasted no time in prompting both houses of Congress to consider change. Could it be that we are poised for a momentous change in this industry, one which will reach every person in the country, ranging from individuals through insurance companies, hospitals to pharmaceutical companies? Now more than ever, the role of healthcare and pharmaceutical consulting organisations will be tested and they will need to bring all their skills to the table to process changes that are sure to come.

Healthcare can be seen as a growth industry for a considerable time ahead as the baby boomer generation starts to age and comes to a period when more strain is likely to be placed on the healthcare system. This will call for innovation and the provision of additional services and products by the pharmaceutical company. The marketplace is sure to get more and more competitive.

A spotlight will always be trained on costs and the role of the insurance company as intermediary between both ends of the spectrum. Healthcare professionals are sure to receive pressure, as they weigh up the advice that they should give their patients in the light of new rules and rafts of legislation. All in all, a great period of uncertainty can be expected in what is already a pressure filled industry.

In the time to come, pharmaceutical consultants will be more valuable than ever as pharma consulting plays its role in deciphering new and complex rules and positions. Training of the company’s workforce is best engaged with the help of consultants, who provide an extra layer of expertise, experience and training themselves. Executives from the parent company must spend as much time as possible dealing with the principal concerns associated with production and regulation. They should devote valuable time to staff administration, maintenance and training. To help ensure that sales executives are deployed correctly and return as high a value as possible to the company, the pharmaceutical consulting firm is ready and willing to take on this important task.

The healthcare business is one of our most dynamic industries and pharmaceutical and healthcare consulting is a critical internal component. Not all organisations interested in the development of a pharmaceutical company can be classified as “friendly” and this puts significant pressures on the company. While the company’s executives struggle with these issues, figuring out how to interpret positions and trying to devise how to approach and deal with each party from a strong position, the pharmaceutical consulting firm can provide valuable backing. The consultant can be a valuable ally and an extra pair of eyes and ears, to help the pharmaceutical company navigate through challenging, risky, yet potentially lucrative times ahead. It is certainly best for the company to take on a long-term engagement with a pharmaceutical and healthcare consulting firm, to achieve the best possible returns.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.

1. Top Sales Force Effectiveness Requires The Right Approach Proper incentivisation is critical to the effectiveness of an organisation’s sales force. This must be...
2. Top Pharmaceutical Consultants Recommend Applying Key Account Management Strategies The 80/20 rule is a metric used within the business world which reveals that fully...
3. EVO II: New Name For Brute Force SEO BruteForce SEO Video - check it out! EVO II is the new name for Brute...